ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,425Medicare Part D Prescriptions Filled, Including Refills

Rank: 72 out of 3722

$2.37M Total Retail Price of All Prescriptions

Rank: 28 out of 3722

652 Patients Receiving at Least One Drug in Part D
81% Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Florida
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 652 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 652 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$78 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 1,075 945 193 1 4
CLOPIDOGREL 904 736 143 2 15
VOLTAREN 808 668 152 3 69
FUROSEMIDE 777 680 122 4 8
SIMVASTATIN 773 654 155 5 1
AMLODIPINE BESYLATE 680 580 134 6 2
LISINOPRIL 660 522 118 7 5
IBUPROFEN 617 461 116 8 57
NAMENDA 612 558 96 9 44
MONTELUKAST SODIUM 607 490 111 10 51
NEXIUM 603 465 110 11 50
LIDODERM 590 452 124 12 116
ADVAIR DISKUS 532 428 106 13 55
METFORMIN HCL 513 367 76 14 7
METOPROLOL TARTRATE 486 426 83 15 9
DIOVAN 466 371 73 16 48
ALPRAZOLAM 420 368 72 B 17 11
LEVOTHYROXINE SODIUM 419 352 68 18 3
DONEPEZIL HCL 407 374 73 19 33
GABAPENTIN 407 329 71 19 16
TRAMADOL HCL 406 364 73 21 20
TEMAZEPAM 397 368 81 B 22 25
CLOTRIMAZOLE-BETAMETHASONE 384 338 84 23 83
CARVEDILOL 368 285 70 24 22
GLIPIZIDE 367 341 61 25 38
ALENDRONATE SODIUM 350 328 62 26 27
FAMOTIDINE* 337 307 65 27 61
CRESTOR 334 274 74 28 24
NITROGLYCERIN PATCH 297 266 56 29 220
ESCITALOPRAM OXALATE 296 253 56 30 47
FENOFIBRATE* 287 211 55 31 53
NOVOLIN 70-30 278 241 45 10 32 132
CELEBREX 267 207 65 33 106
PROAIR HFA 257 217 61 34 58
ZOLPIDEM TARTRATE 238 174 41 35 21
ATENOLOL 236 189 35 36 14
LYRICA 228 183 41 37 100
MECLIZINE HCL 221 210 50 38 93
HYDROCHLOROTHIAZIDE 191 138 40 39 12
AZITHROMYCIN 190 159 130 40 40
RANITIDINE HCL 190 139 31 40 34
ATORVASTATIN CALCIUM 188 161 35 42 6
TAMSULOSIN HCL 183 166 33 43 28
PENTOXIFYLLINE 176 139 31 44 174
EXELON 168 126 27 45 137
NAPROXEN 167 151 36 46 77
POTASSIUM CHLORIDE 166 137 27 47 23
LOSARTAN POTASSIUM 162 138 43 48 10
CLONAZEPAM 155 134 31 B 49 52
DICLOFENAC SODIUM 155 139 34 49 95
DIGOX 152 122 29 51 87
DEXILANT 150 138 32 52 194
NASONEX 146 105 27 53 217
QUETIAPINE FUMARATE 145 125 26 A 54 67
SUCRALFATE 141 136* 27 55 201
SURE COMFORT* 139 120 25 56 206
BENICAR 137 124 31 57 118
HUMULIN 70-30 136 102 22 58 221
SERTRALINE HCL 135 130* 28 59 31
MEGESTROL ACETATE 134 129* 27 R 60 177
METOPROLOL SUCCINATE 134 102 33 60 18
CIPROFLOXACIN HCL 132 100 92 62 56
LOVAZA 124 90 28 63 108
INSULIN SYRINGE* 123 102 22 64 143
CLONIDINE HCL 119 95 19 65 49
IBANDRONATE SODIUM 118 97 22 66 184
LANSOPRAZOLE 116 88 24 67 113
PANTOPRAZOLE SODIUM 114 109* 31 68 29
WARFARIN SODIUM 111 95 13 69 19
AMITIZA 105 92 22 70 257
METOCLOPRAMIDE HCL 101 88 20 71 152
RESTASIS 100 65 23 72 280
COMBIVENT RESPIMAT 99 75 20 73 290
ENALAPRIL MALEATE 99 77 17 73 45
ABILIFY 98 78 30 A 75 156
VESICARE 98 93* 25 75 157
GLYBURIDE-METFORMIN HCL 97 92* 20 R 77 155
PHENYTOIN SODIUM EXTENDED 97 45 17 77 208
NIFEDIPINE ER 97 66 22 77 66
CALCIPOTRIENE 95 69 20 80 322
FLUTICASONE PROPIONATE 92 87* 25 81 32
DICYCLOMINE HCL 90 69 21 82 191
SPIRIVA 90 75 22 82 92
MUPIROCIN* 90 85* 39 82 133
GLYBURIDE 88 66 17 R 85 103
WELCHOL 84 79* 17 86 277
CLOBETASOL PROPIONATE 78 51 17 87 173
LACTULOSE 77 72* 20 88 122
ISOSORBIDE MONONITRATE ER 77 72* 16 88 59
SYMBICORT 71 66* 21 90 123
NAFTIN 71 54 13 90 396
BD ULTRA-FINE PEN NEEDLE 71 57 17 90 162
KETOCONAZOLE 70 51 17 93 128
LANTUS 69 40 18 94 68
SOTALOL 67 <11 <11 95 249
CYMBALTA 67 62* 14 95 70
VENTOLIN HFA 67 62* 13 95 81
PAROXETINE HCL 67 52 15 95 63
LORAZEPAM 65 60* 13 B 99 36
NOVOLOG 64 <11 <11 100 119
ZETIA 64 59* 13 100 82
COMBIVENT 62 46 17 102 365
LIDOCAINE 62 50 30 102 298
PREDNISONE 61 56* 16 104 46
SEROQUEL XR 60 24 15 A 105 210
NOVOLOG MIX 70-30 59 45 12 106 259
CITALOPRAM HBR 58 47 13 107 30
FINASTERIDE 57 <11 <11 108 65
VALSARTAN-HYDROCHLOROTHIAZIDE 57 52* 14 108 85
BENAZEPRIL HCL 57 <11 <11 108 79
CILOSTAZOL 56 <11 <11 111 165
RIVASTIGMINE 56 <11 <11 111 372
FLECTOR 54 49* 11 113 459
AMIODARONE HCL 54 49* 11 113 197
HYDRALAZINE HCL 51 40 15 115 78
TRAZODONE HCL 50 45* 11 116 54
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 19, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.